Sakin S A, Hossain A M, Mahmud S H, Ahmed S M
Dr Saniad Ahmed Sakin, Assistant Professor, Department of Pharmacology & Therapeutics, Brahmanbaria Medical College, Brahmanbaria, Bangladesh; E-mail:
Mymensingh Med J. 2020 Apr;29(2):399-404.
Spontaneous reporting of suspected adverse drug reaction by healthcare professionals is the cornerstone of pharmacovigilance. National pharmacovigilance program of Bangladesh was started to promote the pharmacovigilance activity in this country. But in Bangladesh the pharmacovigilance program is still in its infancy due to lack of reporting culture amongst healthcare professionals of this country. This cross sectional, questionnaire based study was conducted to assess the knowledge, attitudes and practices regarding adverse drug reaction reporting as well as to evaluate the effectiveness of educational intervention to improve the pharmacovigilance status of this country in the Department of Pharmacology & Therapeutics, Sylhet MAG Osmani Medical College (SOMC) in collaboration with the Internal Medicine, Dermatology & Venerology and Cardiology departments of SOMC and Jalalabad Rageeb Rabeya Medical College (JRRMC), Selhet, Bangladesh. A seminar (educational intervention) was conducted for the doctors of Internal Medicine, Dermatology & Venerology and Cardiology departments of SOMCH. The survey questionnaire was administered to 51 doctors who had attended the seminar in SOMCH (interventional group) and 33 doctors who had not attended the seminar in JRRMCH (non-interventional group). The study found that there is significant improvement in intervention group in comparison to non-intervention group in terms of knowledge and attitude about ADR reporting (in all cases those were statistically significant). Inadequate perception about ADR reporting among medical practitioners is the main factor for underreporting, which can be overcome by educational intervention. So, different types of educational intervention should be implemented among medical practitioner in different healthcare facilities for the improvement of the pharmacovigilance status of this country.